Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for large-scale production of Di (uridine 5'-tetraphosphate) and salts thereof

A technology of tetraphosphate and uridine, which is applied in the field of production of therapeutic dinucleotides, can solve problems such as time-consuming, and achieve the effect of reducing time and being easy to handle

Inactive Publication Date: 2000-08-30
MERCK & CO INC
View PDF5 Cites 17 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, existing diuridine tetraphosphate synthesis methods are time-consuming and produce only small amounts of only partially identified diuridine tetraphosphate

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for large-scale production of Di (uridine 5'-tetraphosphate) and salts thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] Method for producing diuridine tetraphosphate tetrasodium salt with uridine 5'-diphosphate

[0047] Uridine 5'-diphosphate disodium salt (Yamasa, Choshi, Japan; 600 g) was dissolved in 5.4 liters of deionized water. Pass the solution through Dowex 50Wx4 H + (Dow Chemical) column. Fractions containing uridine 5'diphosphate were pooled and neutralized with tributylamine (Aldrich, St. Louis; 300 mL). The neutralized fractions were concentrated to an oil using a rotary evaporator at a bath temperature of 55-60°C. The oil was dissolved in dry dimethylformamide (Aldrich, 3 L) and concentrated to an oily dryness using a rotary evaporator (55-60°C bath temperature). Repeat this step twice. The oil was redissolved in 3 liters of dimethylformamide and 1,1-carbonyldiimidazole (Aldrich; 100 g) was added. The solution was heated at 50°C for 2.5 hours. An additional amount of activator (33 g) was added and heating was continued for an additional 2.5 hours. The solution was con...

Embodiment 2

[0054] Method for producing diuridine tetraphosphate tetrasodium salt with uridine 5'-monophosphate

[0055] Uridine 5'-monophosphate (Sigma, Milwaukee, 3.0 g, 9.26 mmol) was dissolved in dry DMF (10 mL) and tributylamine (Aldrich, 2 mL). The solution was evaporated in vacuo at 40°C to an oil. The residue was dissolved in dry DMF (Aldrich, 8 mL) to form a solution. To this solution was added carbonyldiimidazole (Aldrich, 1.65 g, 10.18 mmol). The reaction solution was heated at 50°C for 1 hour. Uridine 5'-triphosphate (Yamasa, 5.60 g, 10.18 mmol) prepared as anhydrous tributylammonium salt (prepared as described in Example 3 below) in 5 mL DMF and 2 mL tributylamine was added to the reaction in solution. The mixture was stirred at 50° C. for 3 days, then the solution was evaporated in vacuo into an oil, redissolved in 5 ml of water, and analyzed by column chromatography (300×50 mm, Sephadex DEAE-A25, 40-120 μ, Aldrich, pre-dissolved in 1.0 M ammonium bicarbonate Medium swe...

Embodiment 3A

[0057] Method for producing diuridine tetraphosphate with uridine 5'-triphosphate (UTP)

[0058] A 5 mL aqueous solution of uridine 5′-triphosphate (UTP) trisodium salt (ProBioSint, Varse, Italy; 5.86 g, 0.01 mol) was passed through a column of BioRad AG-MP 50 (Aldrich) strong cation exchange resin in the form of tributylamine (50 mL bed volume) and eluted with approximately 300 mL distilled water. Tributylamine (Aldrich, 5 mL) was added to this solution, and the suspension was shaken until the pH of the aqueous fraction rose to 8. The layers were separated and the aqueous solution was evaporated to a small volume and then lyophilized overnight. The residue was dissolved in dry dimethylformamide (Aldrich; 20 mL), and the solvent was evaporated at 0.1 mmHg. The dry tributylamine was made up to 100 mL with anhydrous acetone to obtain a stock solution (0.1 M in UTP). Dicyclohexylcarbodiimide was added to an aliquot of the aforementioned UTP solution (10 mL, 1.0 mmol), and the ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides new methods for the synthesis of the therapeutic dinucleotide, P<1>,P<4>-di(uridine 5'-tetraphosphate), and demonstrates applicability to the production of large quantities. The methods of the present invention substantially reduce the time period required to synthesize diurindine tetraphosphate, preferably to three days or less. The novel tetrammonium and tetrasodium salts of P<1>,P<4>-di(uridine 5'-tetraphosphate) formula (I) prepared by these methods are stable, soluble, nontoxic, and easy to handle during manufacture. In formula I, X is Na, NH4 or H, provided that all X groups are not H.

Description

[0001] This application claims priority to US Provisional Application 60 / 054,147, filed July 25,1997. technical field [0002] The present invention relates to methods of producing therapeutic dinucleotides, including novel salts thereof. More specifically, the present invention relates to the synthesis of P 1 ,P 4 - Di(uridine 5′-tetraphosphate) (i.e. diuridine tetraphosphate U 2 P 4 ) better than existing production methods. Background of the invention [0003] P 1 ,P 4 - Bis(uridine 5′-tetraphosphate) is a dinucleotide with the following structure: [0004] Formula I in: [0005] X is Na, NH 4 or H, with the proviso that none of the X groups is H. [0006] P 1 ,P 4 - The free acid of di(uridine 5′-tetraphosphate) (when X is hydrogen) has previously been described as uridine 5′-(pentahydrotetraphosphate), P → uridine 5′ ester (CAS Registry No. : 59985-21-6; C. Vallejo et al., Biochimica et Biophysica Acta 438, 305 (1976...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07H19/10A61K31/7084A61P11/00A61P11/10A61P15/02A61P27/02A61P27/16C07H21/00
CPCC07H21/00A61P11/00A61P11/10A61P15/00A61P15/02A61P27/02A61P27/04A61P27/16
Inventor B·R·耶扎W·彭德格斯特
Owner MERCK & CO INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com